These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 28193736)

  • 21. Regulatory role of CD39 and CD73 in tumor immunity.
    Kaplinsky N; Williams K; Watkins D; Adams M; Stanbery L; Nemunaitis J
    Future Oncol; 2024; 20(19):1367-1380. PubMed ID: 38652041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies.
    Perrot I; Michaud HA; Giraudon-Paoli M; Augier S; Docquier A; Gros L; Courtois R; Déjou C; Jecko D; Becquart O; Rispaud-Blanc H; Gauthier L; Rossi B; Chanteux S; Gourdin N; Amigues B; Roussel A; Bensussan A; Eliaou JF; Bastid J; Romagné F; Morel Y; Narni-Mancinelli E; Vivier E; Paturel C; Bonnefoy N
    Cell Rep; 2019 May; 27(8):2411-2425.e9. PubMed ID: 31116985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidized low-density lipoproteins enhance expression and activity of CD39 and CD73 in the human aortic valve endothelium.
    Kaniewska-Bednarczuk E; Mielcarek M; Chester AH; Slominska EM; Yacoub MH; Smolenski RT
    Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):713-719. PubMed ID: 27906627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility of aging mice to listeriosis: Role of anti-inflammatory responses with enhanced Treg-cell expression of CD39/CD73 and Th-17 cells.
    Alam MS; Cavanaugh C; Pereira M; Babu U; Williams K
    Int J Med Microbiol; 2020 Feb; 310(2):151397. PubMed ID: 31974050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD73 is a phenotypic marker of effector memory Th17 cells in inflammatory bowel disease.
    Doherty GA; Bai A; Hanidziar D; Longhi MS; Lawlor GO; Putheti P; Csizmadia E; Nowak M; Cheifetz AS; Moss AC; Robson SC
    Eur J Immunol; 2012 Nov; 42(11):3062-72. PubMed ID: 22965858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenosine production by human B cells and B cell-mediated suppression of activated T cells.
    Saze Z; Schuler PJ; Hong CS; Cheng D; Jackson EK; Whiteside TL
    Blood; 2013 Jul; 122(1):9-18. PubMed ID: 23678003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice.
    Bao R; Shui X; Hou J; Li J; Deng X; Zhu X; Yang T
    Int J Mol Med; 2016 Sep; 38(3):969-75. PubMed ID: 27430240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inversed Ratio of CD39/CD73 Expression on γδ T Cells in HIV Versus Healthy Controls Correlates With Immune Activation and Disease Progression.
    Kolbe K; Wittner M; Hartjen P; Hüfner AD; Degen O; Ackermann C; Cords L; Stellbrink HJ; Haag F; Schulze Zur Wiesch J
    Front Immunol; 2022; 13():867167. PubMed ID: 35529864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenosinergic Immunosuppression by Human Mesenchymal Stromal Cells Requires Co-Operation with T cells.
    Kerkelä E; Laitinen A; Räbinä J; Valkonen S; Takatalo M; Larjo A; Veijola J; Lampinen M; Siljander P; Lehenkari P; Alfthan K; Laitinen S
    Stem Cells; 2016 Mar; 34(3):781-90. PubMed ID: 26731338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concerted effect of lymphopenia, viraemia and T-cell activation on Fas expression of peripheral B cells in HIV-1-infected patients.
    Rethi B; Sammicheli S; Amu S; Pensieroso S; Hejdeman B; Schepis D; Thang PH; Chiodi F
    AIDS; 2013 Jan; 27(2):155-62. PubMed ID: 23238551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired Upregulation of the Costimulatory Molecules, CD27 and CD28, on CD4
    Tanaskovic S; Price P; French MA; Fernandez S
    AIDS Res Hum Retroviruses; 2017 Feb; 33(2):101-109. PubMed ID: 27701900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD39-mediated effect of human bone marrow-derived mesenchymal stem cells on the human Th17 cell function.
    Lee JJ; Jeong HJ; Kim MK; Wee WR; Lee WW; Kim SU; Sung C; Yang YH
    Purinergic Signal; 2014; 10(2):357-65. PubMed ID: 24043462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-lymphocyte dysfunction in chronic HIV-1 infection does not prevent cross-clade neutralization breadth.
    Boliar S; Murphy MK; Tran TC; Carnathan DG; Armstrong WS; Silvestri G; Derdeyn CA
    J Virol; 2012 Aug; 86(15):8031-40. PubMed ID: 22623771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD73 expression identifies a subset of IgM
    D'Souza L; Gupta SL; Bal V; Rath S; George A
    Immunology; 2017 Dec; 152(4):602-612. PubMed ID: 28746783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of memory (CD27) B lymphocytes in HIV-1 infection.
    De Milito A; Mörch C; Sönnerborg A; Chiodi F
    AIDS; 2001 May; 15(8):957-64. PubMed ID: 11399977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.
    Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF
    Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydroxycarbamide modulates components involved in the regulation of adenosine levels in blood cells from sickle-cell anemia patients.
    Silva-Pinto AC; Dias-Carlos C; Saldanha-Araujo F; Ferreira FI; Palma PV; Araujo AG; Queiroz RH; Elion J; Covas DT; Zago MA; Panepucci RA
    Ann Hematol; 2014 Sep; 93(9):1457-65. PubMed ID: 24696091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B cells from Patients with Rheumatoid Arthritis Show Conserved CD39-Mediated Regulatory Function and increased CD39 Expression After Positive Response to Therapy.
    Zacca ER; Amezcua Vesely MC; Ferrero PV; Acosta CDV; Ponce NE; Bossio SN; Mussano E; Onetti L; Cadile I; Acosta Rodríguez EV; Montes CL; Gruppi A
    J Mol Biol; 2021 Jan; 433(1):166687. PubMed ID: 33098857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD72/CD100 and PD-1/PD-L1 markers are increased on T and B cells in HIV-1+ viremic individuals, and CD72/CD100 axis is correlated with T-cell exhaustion.
    Correa-Rocha R; Lopez-Abente J; Gutierrez C; Pérez-Fernández VA; Prieto-Sánchez A; Moreno-Guillen S; Muñoz-Fernández MÁ; Pion M
    PLoS One; 2018; 13(8):e0203419. PubMed ID: 30161254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated CD39+T-Regulatory Cells and Reduced Levels of Adenosine Indicate a Role for Tolerogenic Signals in the Progression from Moderate to Severe COVID-19.
    Elsaghir A; El-Sabaa EMW; Zahran AM; Mandour SA; Salama EH; Aboulfotuh S; El-Morshedy RM; Tocci S; Mandour AM; Ali WE; Abdel-Wahid L; Sayed IM; El-Mokhtar MA
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.